CDER Conversation: CDER Creates New Biosimilars Resources for Educators, Teaching Facilities
CDER Office of Therapeutic Biosimilars and Biosimilars (OTBB) released its first-ever curriculum toolkit for educators to help students in healthcare professional degree programs improve their understanding of biosimilar and interchangeable products and their regulatory approval pathway in the U.S.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news